Effectiveness of bi-monthly long-acting injectable cabotegravir and rilpivirine as maintenance treatment for HIV-1 in the Netherlands: results from the Dutch ATHENA national observational cohort

Vita W Jongen, Ferdinand W N M Wit, Anders Boyd, Arne van Eeden, Annemarie E Brouwer, Robert Soetekouw, Rachida El Moussaoui, Janneke Stalenhoef, Kim C E Sigaloff, Tatiana Mudrikova, Jet Gisolf, David Burger, Annemarie M J Wensing, Marc van der Valk

Open source

DOI: 10.1016/s2352-3018(24)00269-8
Published: 2025-01
Container: The Lancet HIV
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2352-3018-24-00269-8,
  title = {Effectiveness of bi-monthly long-acting injectable cabotegravir and rilpivirine as maintenance treatment for HIV-1 in the Netherlands: results from the Dutch ATHENA national observational cohort},
  author = {Vita W Jongen and Ferdinand W N M Wit and Anders Boyd and Arne van Eeden and Annemarie E Brouwer and Robert Soetekouw and Rachida El Moussaoui and Janneke Stalenhoef and Kim C E Sigaloff and Tatiana Mudrikova and Jet Gisolf and David Burger and Annemarie M J Wensing and Marc van der Valk},
  year = {2025},
  journal = {The Lancet HIV},
  doi = {10.1016/s2352-3018(24)00269-8},
  url = {https://doi.org/10.1016/s2352-3018(24)00269-8}
}

RIS

TY  - JOUR
TI  - Effectiveness of bi-monthly long-acting injectable cabotegravir and rilpivirine as maintenance treatment for HIV-1 in the Netherlands: results from the Dutch ATHENA national observational cohort
AU  - Vita W Jongen
AU  - Ferdinand W N M Wit
AU  - Anders Boyd
AU  - Arne van Eeden
AU  - Annemarie E Brouwer
AU  - Robert Soetekouw
AU  - Rachida El Moussaoui
AU  - Janneke Stalenhoef
AU  - Kim C E Sigaloff
AU  - Tatiana Mudrikova
AU  - Jet Gisolf
AU  - David Burger
AU  - Annemarie M J Wensing
AU  - Marc van der Valk
PY  - 2025
JO  - The Lancet HIV
DO  - 10.1016/s2352-3018(24)00269-8
UR  - https://doi.org/10.1016/s2352-3018(24)00269-8
ER  -

APA

Jongen, V. W., Wit, F. W. N. M., Boyd, A., Eeden, A. V., Brouwer, A. E., Soetekouw, R., Moussaoui, R. E., Stalenhoef, J., Sigaloff, K. C. E., Mudrikova, T., Gisolf, J., Burger, D., Wensing, A. M. J., & Valk, M. V. D. (2025). Effectiveness of bi-monthly long-acting injectable cabotegravir and rilpivirine as maintenance treatment for HIV-1 in the Netherlands: results from the Dutch ATHENA national observational cohort. The Lancet HIV. https://doi.org/10.1016/s2352-3018(24)00269-8

Source records

crossref · retrieved 2026-09-26T20:05:53.328Z